The 3rd Annual Biomarkers Congress
Venue: The Midland Hotel
|Event Date/Time: May 14, 2008||End Date/Time: May 15, 2008|
The 3rd annual Biomarkers World Congress 2008, presented by Oxford Global Conferences, provides a first class educational and networking opportunity for over 200 attendees to gain knowledge and insights into the Biomarkers marketplace.
It explores core topics such as integration of applications and enabling technologies, molecular diagnostics and assay development, imaging in preclinical and clinical development; biomarker discovery & validation in different therapeutic areas such as Oncology, CNS and Cardiovascular, biomarkers in translational discovery and clinical development, and toxicity biomarkers. Do not miss out on the opportunity to learn insights on how you can streamline your R&D process and identify potential cost savings through successful biomarker discovery, validation and clinical development. Over the 2 days, the comprehensive and scientific conference programme will feature key note addresses, case study presentations, panel and roundtable discussions of over 65 senior level industry speakers from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions covering the following hot topics:
• Integration of technologies & applications to bridge the gap between Discovery, Validation and Development
• Biomarker Discovery and Development in Translational Research
Biomarker Discovery and Validation: Accelerating discovery and validation through Genomics, Protein, Metabolic biomarkers as well as application of biomarker technologies in different therapeutic areas such as Oncology, CNS, Cardiovascular.
Molecular Diagnostics, Data Integration, Data Analysis, Modelling and Bioinformatics: Exploiting tools and technologies to deliver personalised medicine, and successful integration of these tools within the preclinical and development process
Imaging in Preclinical and Clinical Development & Assay Validation & Development: Profiting from application of imaging technologies and techniques in preclinical and clinical drug development
Biomarkers in Clinical Development: Aligning biomarker discovery clinical development, and clinical trial activity to improve safety and efficacy
Toxicity Biomarkers: How biomarkers lower attrition rates and adverse events in preclinical and clinical development activities
WHO YOU WILL MEET
Over 200 senior attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, academics, government, CRO and solution provider companies will be attending. Meet senior VPs, Directors, and Managers from the following job titles:
Biomarker, Toxicity, Safety, Clinical Pharmacology, Translational Research, Clinical Discovery, Clinical Research, Molecular Informatics, Diagnostics, Pharma Development, Genomics, Proteomics, Biomarker Discovery, R&D, Statistical Biomarker Research, Molecular Biology, CSO, Metabolomics, Toxicoinformatics Pharmacogenomics, Pharmacogenetics, Experimental Medicine, Imaging, Discovery Oncology, Clinical Oncology, Discovery Medicine, Biological Sciences, Pharmaometrics, Pharmacokinetics
THE NEW EVENT FORMAT: NETWORKING AND BUSINESS MEETING OPPORTUNITIES
Meet the speakers and your peers
In addition to the full conference agenda, this event offers you the chance to meet face-to-face with leading industry solution providers and senior-level industry peers through a series of formal and informal networking opportunities.
Meet the speakers and delegates through roundtable discussions
A selection of our key speakers will be hosting focused discussion groups to drill down into their areas of expertise. Lasting for 40 minutes to an hour, each session will start with a brief presentation from the speaker followed by a roundtable debate.
Meet solution providers
Use our online appointment system to contact solution providers prior to the event and to pre-arrange one-to-one meetings with them. Discuss technologies, services and solutions that address your key business concerns.